Literature DB >> 10397700

Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells.

C Rosnoblet1, U M Vischer, R D Gerard, J C Irminger, P A Halban, E K Kruithof.   

Abstract

Tissue-type plasminogen activator (t-PA) is acutely released by endothelial cells. Although its endothelial storage compartment is still not well defined, t-PA release is often accompanied by release of von Willebrand factor (vWf), a protein stored in Weibel-Palade bodies. We investigated, therefore, whether t-PA is stored in these secretory organelles. Under basal culture conditions, a minority of human umbilical vein endothelial cells (HUVEC) exhibited immunofluorescent staining for t-PA, which was observed only in Weibel-Palade bodies. To increase t-PA expression, HUVEC were infected with a t-PA recombinant adenovirus (AdCMVt-PA). Overexpressed t-PA was detected in Weibel-Palade bodies and acutely released together with endogenous vWf by thrombin or calcium ionophore stimulation. In contrast, plasminogen activator inhibitor type 1 and urokinase were not detected in Weibel-Palade bodies after adenovirus-mediated overexpression. Infection of HUVEC with proinsulin recombinant adenovirus resulted in the storage of insulin in Weibel-Palade bodies, indicating that these organelles can also store nonendothelial proteins that show regulated secretion. Infection of AtT-20 pituitary cells, a cell type with regulated secretion, with AdCMVt-PA resulted in the localization of t-PA in adrenocorticotropic hormone-containing granules, indicating that t-PA can be diverted to secretory granules independently of vWf. Coinfection of AtT-20 cells with AdCMVt-PA and proinsulin recombinant adenovirus resulted in the colocalization of t-PA and insulin in the same granules. Taken together, these results suggest that HUVEC have protein sorting mechanisms similar to those of other regulated secretory cells. Although the results did not exclude an alternative storage site for t-PA in HUVEC, they established that t-PA can be stored in Weibel-Palade bodies. This finding may explain the acute coordinate secretion of t-PA and vWf.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397700     DOI: 10.1161/01.atv.19.7.1796

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells.

Authors:  S Schnyder-Candrian; L Borsig; R Moser; E G Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 2.  Molecular and cellular biology of von Willebrand factor.

Authors:  Cécile V Denis
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

3.  Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP.

Authors:  John H Cleator; Wen Qin Zhu; Douglas E Vaughan; Heidi E Hamm
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

4.  Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.

Authors:  J E Kaufmann; A Oksche; C B Wollheim; G Günther; W Rosenthal; U M Vischer
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

5.  Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase.

Authors:  Victor Garcia; Eon Joo Park; Mauro Siragusa; Florian Frohlich; Mohammad Mahfuzul Haque; Jonathan V Pascale; Katherine R Heberlein; Brant E Isakson; Dennis J Stuehr; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-16       Impact factor: 11.205

6.  Ultrastructure Study of Transgenic Ren2 Rat Aorta - Part 1: Endothelium and Intima.

Authors:  Melvin R Hayden; Javad Habibi; Tejaswini Joginpally; Poorna R Karuparthi; James R Sowers
Journal:  Cardiorenal Med       Date:  2012-01-27       Impact factor: 2.041

7.  Rab3D and annexin A2 play a role in regulated secretion of vWF, but not tPA, from endothelial cells.

Authors:  Markus Knop; Elin Aareskjold; Günther Bode; Volker Gerke
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

8.  t-PA reduces ischemic impairment of blood-brain barrier by strengthening endothelium junction.

Authors:  Zhongling Zhang; Xuhui Chen; Le Li; Keling Zhang; Shuqing Tian; Hongmei Gao; Hulun Li
Journal:  Neurol Sci       Date:  2013-02-20       Impact factor: 3.307

9.  Quantification of heparin-induced TFPI release: a maximum release at low heparin dose.

Authors:  Michiel J B Kemme; Jacobus Burggraaf; Rik C Schoemaker; Cornelis Kluft; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

10.  New transgenic evidence for a system of sympathetic axons able to express tissue plasminogen activator (t-PA) within arterial/arteriolar walls.

Authors:  Zhifang Hao; Caiying Guo; Xi Jiang; Susan Krueger; Thomas Pietri; Sylvie Dufour; Robert E Cone; James O'Rourke
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.